Exciting news from Evolution Therapeutics as we welcome Alice Wigington, who has joined the team as a Research Scientist.
Alice is a first-class graduate of Aston University’s integrated master’s programme in Biological Sciences, bringing strong expertise in immunoassay-based research and translational laboratory science. Her scientific background is closely aligned with Evolution Therapeutics’ mission to develop innovative nanoparticle-based therapies to address unmet clinical needs.
In her role at Evo, Alice will support the advancement of the company’s wound-healing platform, contributing to experimental design, data generation and the continued development of the preclinical pipeline. Alongside her technical expertise, she brings extensive experience from collaborative and customer-facing roles, strengthening the team’s mission-driven culture.
We’re delighted to have Alice on board and look forward to her contributions as Evolution Therapeutics continues to grow.